IP Library Granted Patent US 8,394,378
Granted Patent B2
US 8,394,378 · App. 13/245,299 · Granted Mar 12, 2013

Antibodies binding human collagen II

Inventors: John Kehoe (Radnor, PA); Jennifer Lee Gardiner (Seattle, WA); Tatiana Ort (Radnor, PA); Kristen Picha (Radnor, PA); Mary Ryan (Radnor, PA); John Wheeler (Radnor, PA)
Assignee: Janssen Biotech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,378
App. No.
13/245,299
Granted
Mar 12, 2013
Kind
B2
Abstract

The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.

Claims (8)

1. An isolated monoclonal antibody or fragment thereof that binds human collagen II, selected from the group consisting of:

i. a VH region and a VL region, wherein the VH region comprises the HCDRI, HCDR2, and HCDR3 sequences as shown in SEQ ID NO: 11, 17, and 30, respectively, and the VL region comprises the LCDRI, LCDR2, and LCDR3 sequences as shown in SEQ ID NO: 34, 42, and 47, respectively,

ii. a VH region and a VL region, wherein the VH region comprises the HCDRI, HCDR2, and HCDR3 sequences as shown in SEQ ID NO: 9, 15, and 28, respectively, and the VL region comprises the LCDRI, LCDR2, and LCDR3 sequences as shown in SEQ ID NO:s 39, 42, and 53, respectively, and

iii. a VH region and a VL region, wherein the VH region comprises the HCDRI, HCDR2, and HCDR3 sequences as shown in SEQ ID NO: 13, 19, and 32, repectively, and the VL region comprises the LCDRI, LCDR2, and LCDR3 sequences as shown in SEQ ID NO: 41, 42, and 55, respectively.

2. An isolated monoclonal antibody or fragment thereof that bind human collagen II, comprising a VH region and a VL region, wherein the VH region comprises an amino acid sequence having a sequence shown in SEQ ID NO: 64, 66 or 68 and the VL region comprises an amino acid sequence having a sequence shown in SEQ ID NO: 75, 76, or 5.

3. The isolated antibody of claim 1 , wherein the antibody comprises a Fab fragment.

4. An isolated monoclonal antibody or fragment thereof that binds human collagen II, comprising a heavy chain variable region comprising the amino acid sequence shown in SEQ ID NO: 64, 66 or 68.

5. An isolated monoclonal antibody or fragment thereof that binds human collagen II, comprising a light chain variable region comprising the amino acid sequence shown in SEQ ID NO: 75 or 76.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2012
From: KEHOE, JOHN; ORT, TATIANA; PICHA, KRISTEN; RYAN, MARY; WHEELER, JOHN; GARDINER, JENNIFER LEE
To: JANSSEN BIOTECH, INC.
Reel/Frame 027590/0204 →
Continuity (2)
Provisional Application 61386796 · Sep 27, 2010
Related Publication 20120108795A1 · May 3, 2012